Qianhong Pharmaceutical's first-half 2026 net profit falls 40.78% to 153 million yuan

CLS··CN·Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Qianhong Pharmaceutical released its 2026 semi-annual report, achieving operating revenue of 758 million yuan, down 12% year-on-year. Net profit attributable to shareholders of the listed company was 153 million yuan, down 40.78% year-on-year. The company's second-quarter net profit was 68 million yuan, down 20% quarter-on-quarter from 85 million yuan in the first quarter.

Impact on assets 1

Others▼ · 1 stocks